ArthroCare's spinal surgery system gets FDA go-ahead:
This article was originally published in Clinica
Executive Summary
ArthroCare has received US FDA 510(k) clearance to specifically label the company's Coblation-based spinal surgery system for use in neurosurgery. The products are being commercialised through a strategic partnership with Integra NeuroSciences in North and South America and certain other international markets, said ArthroCare of Sunnyvale, California.